- Language: English
- 17 Pages
- Published: October 2013
- Region: Global
Disease and Therapy Review: Multiple Sclerosis
- ID: 463752
- November 2012
- Region: Global
- 15 Pages
- Timely Data Resources, Inc
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.
Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
The Multiple Sclerosis Disease and Therapy Review provides and overview of the disease and its types, global patterns and incidence and prevalence numbers for major countries worldwide. Information on treatment is provided, as well as treatment and dosing costs of MS drugs. General information on the MS market, as well as sales of leading drugs and therapies are provided.
General description of the condition
Types of multiple sclerosis
II. INCIDENCE AND PREVALENCE
Incidence Table (US, Denmark, France, Italy, Spain, UK, Taiwan, Africa, Americas, Eastern Mediterranean, Europe, Western Pacific, Worldwide)
Prevalence Table (Canada, US, Denmark, England and Wales, France, Germany, Italy, Spain, UK, China, India, Japan, Taiwan, Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, Western Pacific, Worldwide)
Disease modifying agents
IV. DOSING AND TREATMENT COSTS
Dosing for commonly prescribed drugs
Costs for commonly prescribed non-generic drugs
V. MARKET SIZE
Sales information for key pharmaceuticals